LifeMD (LFMD) Competitors $12.15 -0.30 (-2.41%) As of 12:07 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFMD vs. LFST, WGS, VCYT, ARDT, ADUS, PGNY, NHC, PACS, GRAL, and AHCOShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include LifeStance Health Group (LFST), GeneDx (WGS), Veracyte (VCYT), Ardent Health Partners (ARDT), Addus HomeCare (ADUS), Progyny (PGNY), National HealthCare (NHC), PACS Group (PACS), Grail (GRAL), and AdaptHealth (AHCO). These companies are all part of the "healthcare" industry. LifeMD vs. LifeStance Health Group GeneDx Veracyte Ardent Health Partners Addus HomeCare Progyny National HealthCare PACS Group Grail AdaptHealth LifeMD (NASDAQ:LFMD) and LifeStance Health Group (NASDAQ:LFST) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, risk, profitability, analyst recommendations, dividends, media sentiment and valuation. Is LFMD or LFST more profitable? LifeStance Health Group has a net margin of -7.90% compared to LifeMD's net margin of -12.06%. LifeMD's return on equity of 0.00% beat LifeStance Health Group's return on equity.Company Net Margins Return on Equity Return on Assets LifeMD-12.06% N/A -36.34% LifeStance Health Group -7.90%-6.66%-4.51% Does the media favor LFMD or LFST? In the previous week, LifeMD had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 9 mentions for LifeMD and 3 mentions for LifeStance Health Group. LifeMD's average media sentiment score of 0.92 beat LifeStance Health Group's score of 0.90 indicating that LifeMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation and earnings, LFMD or LFST? LifeMD has higher earnings, but lower revenue than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeMD$234.01M2.42-$20.60M-$0.34-36.62LifeStance Health Group$1.28B1.78-$186.26M-$0.10-58.80 Which has more risk & volatility, LFMD or LFST? LifeMD has a beta of 2.42, indicating that its share price is 142% more volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Do institutionals & insiders have more ownership in LFMD or LFST? 35.5% of LifeMD shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 18.4% of LifeMD shares are owned by insiders. Comparatively, 3.2% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend LFMD or LFST? LifeMD presently has a consensus price target of $11.00, suggesting a potential downside of 11.65%. LifeStance Health Group has a consensus price target of $8.50, suggesting a potential upside of 44.56%. Given LifeStance Health Group's higher possible upside, analysts plainly believe LifeStance Health Group is more favorable than LifeMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeMD 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.00LifeStance Health Group 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.83 Does the MarketBeat Community prefer LFMD or LFST? LifeMD received 24 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 76.92% of users gave LifeMD an outperform vote while only 34.04% of users gave LifeStance Health Group an outperform vote. CompanyUnderperformOutperformLifeMDOutperform Votes4076.92% Underperform Votes1223.08% LifeStance Health GroupOutperform Votes1634.04% Underperform Votes3165.96% SummaryLifeMD beats LifeStance Health Group on 11 of the 17 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMD vs. The Competition Export to ExcelMetricLifeMDOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$565.83M$1.79B$5.51B$8.63BDividend YieldN/AN/A5.27%4.18%P/E Ratio-19.4528.0027.1720.15Price / Sales2.421.74410.84161.53Price / CashN/A36.0138.2534.64Price / Book83.0018.026.964.72Net Income-$20.60M-$52.07M$3.23B$248.00M7 Day Performance-1.58%-0.52%6.40%4.54%1 Month Performance50.73%17.85%13.89%10.02%1 Year Performance64.68%77.72%32.16%14.88% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDLifeMD1.5901 of 5 stars$12.15-2.4%$11.00-9.5%+65.1%$552.19M$234.01M-18.98230LFSTLifeStance Health Group2.1029 of 5 stars$5.88-1.0%$8.50+44.6%+4.1%$2.29B$1.28B-22.626,640WGSGeneDx3.2659 of 5 stars$74.13+4.1%$86.75+17.0%+189.6%$2.12B$330.14M-37.821,200Positive NewsVCYTVeracyte4.1998 of 5 stars$26.74+0.5%$40.90+53.0%+34.9%$2.09B$463.39M-178.27790ARDTArdent Health Partners3.2773 of 5 stars$14.43-0.4%$20.67+43.3%N/A$2.06B$6.02B8.8524,200Positive NewsADUSAddus HomeCare4.5724 of 5 stars$111.20+0.3%$142.57+28.2%+1.8%$2.05B$1.21B25.4533,200Positive NewsPGNYProgyny1.0437 of 5 stars$21.70+0.9%$23.45+8.1%-20.4%$1.84B$1.21B37.41310Positive NewsNHCNational HealthCareN/A$103.58-0.5%N/A+1.3%$1.60B$1.37B12.9812,400Positive NewsPACSPACS Group3.6201 of 5 stars$9.83-0.9%$34.29+248.8%-64.7%$1.50B$3.56B0.0032,433GRALGrail0.3721 of 5 stars$37.50-2.4%$31.50-16.0%N/A$1.35B$130.71M-0.611,360AHCOAdaptHealth3.3105 of 5 stars$8.75-2.6%$13.40+53.1%-21.3%$1.21B$3.25B-5.3010,900Positive News Related Companies and Tools Related Companies LifeStance Health Group Competitors GeneDx Competitors Veracyte Competitors Ardent Health Partners Competitors Addus HomeCare Competitors Progyny Competitors National HealthCare Competitors PACS Group Competitors Grail Competitors AdaptHealth Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMD) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.